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INTRODUCTION 
Objectives of this study 
Recent work has shown that western equine encephalitis 
virus (WEE) exists in at least three antigenic phases. The 
purpose of this study was to determine if these antigenic 
phase variations are manifest in the WEE serum antibodies of 
individuals presumably infected with various phases of the 
virus sometime during their lifetime. Attempts were also 
made to correlate the geographic distribution of the virus 
strain type (phase) with antibody type. 
For these purposes hemagglutlnation-inhibition (HI) 
tests and neutralization (Neut) tests were performed with 
two antigenic variants of WEE virus using sera from U. S. 
Military recruits known to possess HI antibodies to WEE. 
Antigenic Classification of Arboviruses 
An arthropod-borne virus (arbovirus) is defined as a 
virus which can multiply in the body of an arthropod and 
which can be biologically transmitted to vertebrates by the 
anthropod. The arbovirus does not cause any known pathologi¬ 
cal change in the arthropod vector but may cause illness in 
the vertebrate host (1). 
In 1901 Reed isolated the first such virus, yellow 
fever, which he showed to be carried by Aedes aegypti and 
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transmitted by this mosquito to man (2). Since that time 
more than 15>0 viruses have been classified as arboviruses (3). 
Many of these cause no known disease, and indeed many have 
not been isolated from arthropods (Ip—6) • These viruses 
have been classified as arboviruses primarily because of 
their serological relationships. Antigenic relationships 
among the arboviruses have become more and more important as 
their number grows, and more detailed subdivisions become 
ne cessary. 
Among the first investigators to note antigenic simi¬ 
larities among the arboviruses was Sraithburn (7), who in 
194-1 found that West Nile (WN), St. Louis encephalitis (SLE) 
and Japanese B encephalitis (JBE) viruses would cross react 
serologically in the neutralization test. Two years later 
it was reported by Havens (8) that eastern equine encephali¬ 
tis (EEE) virus would cross react with WEE in the comple¬ 
ment-fixation test. Casals (9) in 1944- applied several 
tests to the viruses of Russian spring-summer encephalitis 
(RSSE), louping ill (LI), WEE, JBE, SLE, and WN. He found 
RSSE and LI to be closely related by the complement-fixation 
test but not by the mouse intercerebral cross resistance 
test. He found WEE to be unrelated to these viruses by any 
test. 
Serological relationships between arboviruses were 
clarified by Casals and Brown (10) in 1951+ when they reported 
classifying sixteen arboviruses into two groups, A and B, 
. 
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according to their cross reactivity in the hemagglutination- 
inhibition (HI) test. Mouse immune serum for any sero- 
group A virus would inhibit the agglutination of chick red 
cells by all serogroup A viruses. Any serogroup B Immune 
serum would do the same for all serogroup B viruses, but 
there was no cross inhibition between the immune sera of 
one serogroup and a virus of the other. They found that 
the best hemagglutination with serogroup A viruses was at 
37°C at pH 6.4* while serogroup B viruses hemagglutinated 
best at either 4°C or 22°C at pH 7. They placed EEE, 
Semliki forest (SF), Sindbis, Venezuelan equine encephali¬ 
tis (VEE), and WEE viruses into serogroup A and dengue types 
1 and 2, Ilheus, JBE, LI, Ntaya, SLE, RSSE, Uganda S, WN, 
and yellow fever viruses into serogroup B. 
In later work Casals (1,6) described the serogroup C 
viruses. These were five viruses isolated from animals at 
the virus center in Belem, Brazil. These five viruses, Apeu, 
Marituba, Murutucu, Caraparu, and Oriboca, were related to 
one another by either the HI or Neut tests but did not cross 
react with members of serogroups A or B. A sixth virus, 
Itaqui, was later added to serogroup C by Causey (4). 
The fourth serogroup of arboviruses to be classified 
differed from the preceding three in that they were related 
by complement-fixation and not by cross reaction in the HI 
test. This was the Bunyamwera serogroup reported by Casals 
and Whitman (11) in I960. The members of this group were 
. 
. 
. 
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isolated in widely separated areas: Bunyamwera from Uganda, 
Africa; Wyeomyia from Columbia, South America; Cache Valley 
from Utah, U.S.A.; Kairi from Trinidad, West Indies; and 
Germiston, a possible member, from South Africa. A fifth 
serogroup which, like Bunyamwera, had to be grouped by CP 
test because of its poor hemagglutinin properties was the 
Guama complex made up of Guama and Catu from Brazil, and 
Bimiti from Trinidad, West Indies (5>)• 
The delineation of these serogroups may have importance 
in other areas besides taxonomy. Casals (1) showed that 
prior infection of laboratory animals with virus from one 
serogroup would give significant protection against infection 
with another virus of the same serogroup. In human sera from 
Trinidad he found that sera with neutralizing antibodies 
against dengue type 2 were capable of protecting mice 
against infection initiated by interperitoneal inoculation 
with yellow fever. Stamm and Kissling (12) found that birds 
that had survived an infection with EEE in the laboratory 
had a viremia of significantly lower titer and shorter dura¬ 
tion when infected with WEE than did controls not previously 
infected with EEE. In experiments with human volunteers 
Price (13) showed that an injection of live WN virus followed 
by one of killed JBE produced higher titers against JBE, SLE, 
and Murray Valley viruses than did immunization with two 
injections of killed JBE. Working with serogroup A arbo¬ 
viruses, Hearn (lip) in 19&3 found that one injection of mice 
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with an attenuated strain of VEE (9t strain) protected ani¬ 
mals against otherwise lethal doses of EEE and Semliki 
forest viruses. 
As immunological characterization of the arboviruses 
progressed it was shown that the antigenic properties of many 
of the serotypes previously recognized overlapped to such an 
extent that questions arose as to their true ant igenic dis¬ 
tinctness (15). Some of the early work in this field led 
Hammon (16) to suggest that the arboviruses may have arisen 
from a common "stem virus" and developed antigenic diversifi¬ 
cation due to host selection of mutant strains, just as 
certain growth media will select mutant strains of bacteria. 
Arbovirus Strain Variation 
The antigenic uniqueness of the arbovirus serotypes has 
become even less clear in recent years as data have accumula¬ 
ted showing that strains of the same arbovirus may have 
antigenic differences. 
In 19ij-5 Olitsky (1?) reported that mice vaccinated with 
the Rockefeller Institute strain of WEE did not produce pro¬ 
tective antibody against infection with other WEE strains. 
He further showed that this phenomenon was not evident when 
mice were challenged with the strain used for immunization. 
He postulated that the antigenic properties of the immunizing 
strain had changed after numerous mouse passages in the 
laboratory. 
In I960 Clarke (15) conducted experiments in which she 
, 
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took serum from animals immunized with one strain of an 
arbovirus and mixed it with a second strain of the same 
virus. This second strain would adsorb any heterologous 
antibodies but leave in the serum antibodies unique to the 
immunizing strain. By means of this antibody adsorption 
technique she found that strains of yellow fever virus 
isolated in the New World lacked an antigen present in 
African strains of the same virus. She also found that the 
17-B strain of yellow fever used for vaccination had ac¬ 
quired an antigen during its process of attenuation that 
was not present in the parent strain. However, Clarke also 
found that three strains of WN virus were antigenically 
identical in spite of their isolation in different countries 
and from different hosts over a period of fifteen years. 
Other workers have shown changes in the infectivity 
of strains of arboviruses after repeated laboratory 
passages (18,19), as well as changes in the morphology of 
tissue culture plaques formed by arboviruses after a number 
of culture passages (20,21), These changes have been bio¬ 
logical in nature and not associated with changes in the 
antigenicity of the virus strain. 
Evidence that there may exist two biologically dis¬ 
tinct sub-populations of virus particles within a given 
strain population was advanced by Dunayevich and Johnson (22) 
in 1961 in their studies on the "interference effect” seen 
with WEE. This "interference effect" was the name given 
. 
. 
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to the paradoxical survival of young adult mice when given 
large doses of WEE intercerebrall y, while other mice die 
when given more dilute suspensions of virus* These investi¬ 
gators found that they could select certain clones of 
virus from tissue culture that would be non-pathogenic for 
young adult mice and would grow as a pure line of virus. 
They postulated that within certain strains of WEE virus 
there were two particle populations, pathogenic and non- 
pathogenic. Work done at Yale by Henderson (23,2Lj.) has 
shown antigenically distinct sub-populations of virus 
making up various strains of WEE. These experiments are 
discussed later. 
Strain Variation of Viruses other than Arboviruses 
The existence of virus strains showing different anti¬ 
genic characteristics and containing within themselves 
distinct sub-populations has been known for some time with 
the influenza viruses. Priedewald (25) in 19kb- using anti¬ 
body adsorption techniques similar to those used later by 
Clarke (15) for the arboviruses, showed differences in the 
antigenic structure of several strains of influenza A 
virus. In the same year Burnet (25) in Australia showed 
that a strain of influenza isolated in Melbourne in 1935 
had changed antigenic structure after a number of passages 
in eggs. A few years later Francis (27) in the United States 
showed much the same thing with a strain passed through 
tissue culture and eggs, while the same strain passaged in 
, 
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mice retained its original antigenicity. 
Extensive work with antibody adsorption by Hirst (28) 
and later by Jensen and Francis (29) confirmed the findings 
of antigenic variation among a large number of strains of 
influenza A. It was shown that there were at least 18 
different antigens distributed in vaiy ing proportions among 
29 strains of influenza A tested. In 1959 Choppin and 
Tamm (30) reported that strains of influenza A2 were com¬ 
posed of two kinds of virus particles which they designated 
S/ and S— • The S/ were highly sensitive to serum inhibi¬ 
tors, agglutinated red blood cells treated with V. cholerae 
filtrate, and eluted slowly or not at all from red blood 
cells. The S«= particles, however, showed none of these 
properties. In later work (31) they succeeded in establish¬ 
ing pure strains of S/ and S- particles and found that the 
natural strains of influenza A2 varied widely in their 
ratio of S/ to S« particles and that the properties of each 
strain were related to this ratio. Repeated passages of 
mixtures of S/ and S- particles in chick embryos showed an 
increase in the S/ to S- ratio regardless of the ratio of 
the original mixture. Lief (32) in 19&U reported that the 
S/ and S- particles were anti genically different by comple¬ 
ment-fixation. 
Studies with poliovirus have shown there were also 
variations in the antigenic characteristics of strains of 
this virus. Wenner (33) in 1958 in an analysis of 18 
* 
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strains of type 2 polio virus found that they could be 
classified into three groups. There was also some evidence 
that strains isolated in the same geographic area were more 
closely related than strains from other parts of the country. 
Studies of this type led to investigations of anti¬ 
genic variation among strains of WEE virus. It may be of 
interest to consider the history and epidemiology of this 
virus before relating more specific studies of its antigenic 
character. 
Western Equine Encephalitis Virus 
History 
Epizootics of a febrile disease of horses, associated 
with a staggering gait and later, paralysis and death, have 
been known in the United States since at least 1814-7. The 
most widespread epizootic was in 1912 and centered in 
Nebraska and Kansas where 35*000 horses died (3I4.). The 
nature of the disease was not known until 1930 when Meyer (35) 
isolated the virus of WEE from the brains of dead horses 
during an epizootic in the San Joaquin Valley of California. 
It was in 1938 that the first human case of WEE was authenti¬ 
cated. This was a fatal case in a 20 month old boy admitted 
to Fresno County Hospital in California. Howitt (36) 
succeeded in isolating the virus from the brain stem. 
There were numerous epidemics and epizootics in the 
mid and far west during the 1940's (37-U4)* "but it was not 
until 1955 that the virus was isolated East of the Appalachians. 
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This isolation was made by Holden (45) from an English 
sparrow in New Jersey. He also found neutralizing anti¬ 
bodies in pheasants caged in the same area and concluded 
from the ages of the birds that WEE had been active in New 
Jersey in 1952 and 1953* 
The first human infection in the East was reported by 
Pauli (46) in I960. This was a non-fatal case in a 16 year 
old boy in Pawtucket, Rhode Island. No virus was isolated, 
and diagnosis was based upon a rise in complement-fixation 
antibody. 
Epidemiology 
When the virus of WEE was isolated in 1930 there was 
no ready explanation for the spread of the disease (34)« 
Three years later Kelser (47) was able to transmit WEE to 
a horse by means of Aedes aegypti mosquitoes previously fed 
on infected guinea pigs in the laboratory. A naturally 
infected arthropod was not found until 1940 when Kitselman 
and Grundmann (46) isolated WEE from "kissing bugs" (Triatoma 
sanguisuga) in a pasture in Kansas where fatal equine cases 
had occurred the year before. In subsequent work, hcwever, 
they were unable to transmit the virus to laboratory animals 
by means of T, sanguisuga. 
Hammon (49) in 1941 isolated WEE virus from a pool of 
Culex tarsalis mosquitoes during an epidemic in the Yakima 
Valley in Washington. The following year Haitmon (50) re¬ 
ported five more isolations from C. tarsalis in this Yakima 
. 
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. 
# 
11 
Valley, and In 1945 he reported IpX isolations of WEE from 
C. tarsalis during a 1942 epidemic in Washington (39). 
There have been numerous other isolations of WEE virus 
from Culex tarsalis (39,51-54), and most workers accept this 
mosquito as the principle vector of WEE virus in the West (16). 
Reaves (55) has found that the virtual disappearance of WEE 
from a formerly endemic area was coincident with a great 
decline in the C. tarsalis population of the area after the 
introduction of DDT. 
Birds, and in particular domestic fowl, have often been 
shown to be infected with WEE virus. Hammon (5&) in 1942 
found that 50$ of domestic fowl and 17$ of wild birds in 
Washington had neutralizing antibodies. In an endemic area 
of Califomia he also found 26$ of chickens to have neutraliz¬ 
ing antibodies (39)* In addition. Burroughs (5D found 13$ 
of chickens tested in Minnesota had antibodies. Other birds 
found to have a high percentage of sera-containing WEE anti¬ 
body include pheasants (45), ducks (57)> and pigeons (58)* 
This evidence of avian infection with WEE lends more support 
to the implication of C. tarsalis as a vector, since this 
mosquito feeds heavily on birds, particularly domestic fowl 
(39,51,59). It has also been shown that the viremia level 
necessary to infect C_, tarsalis is lower than for most other 
mosquitoes (60). 
From these data emerges the picture of WEE as a disease 
having a mosquito-bird-mosquito cycle with man or horse as 
. 
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an accidental host (53)* Hammon and Reeves (lj.2,61) point 
out that while this cycle may function in this manner in 
the irrigated valleys of the far west there may be a 
different cycle in the dry, open farmlands of the midwest. 
As evidence they note the low rate of infection found in 
fowl in epidemic areas of Texas, Colorado, and Nebraska. 
Although the number of isolations in C. tarsalis far exceed 
those for any other mosquito the following have all been 
considered as vectors: Aedes dorsalis, Aedes vexens, 
Aedes aegypti, Aedes triseriatus, Aedes atropalpus. Aedes 
nigromaculis, Aedes sollicitans» Culex stigmatosa, Culex 
pipens, Culex restuans. Culesita inornate, Fsorphora 
discolor, Orthopodomyia signifera, and Anopheles rnaculipen- 
nis freeborn! (14.2,61,62). 
Sulkin (38) in I9I4-S reported isolating WEE from 
chicken mites (Dermanyssus gallinae) in Texas from a farm 
where an equine case had occurred. Although other workers 
have tested thousands of chicken mites, no other isolation 
has been reported (39,l|.2,5l »6l) • There is evidence that 
in some exceptional cases bird to bird transmission may 
occur without arthropod intervention. Reeves (63) found 
that wild birds placed in a mosquito proof aviary with 
artificially infected birds developed neutralizing anti¬ 
bodies to WEE. Burton (57) found that ducks given large 
doses of WEE orally developed a viremia and neutralizing 
antibodies. Winn and Palmer (6I4.) report that pigeons 
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inoculated with WEE virus were found to have virus in their 
crop 18 to 96 hours after inoculation, although virus could 
not be recovered from their feces. Since young birds are 
fed on food regurgitated from their parents’ crop they 
suggest this may be a route of infection for the young. 
There is still a considerable problem as to how WEE 
is maintained in an area over the winter. Blackmore and 
Winn (5U) suggest three possibilities: 1) migrating birds 
bring the virus north each spring, 2) arthropods other than 
mosquitoes harbor the virus in the winter and infect birds 
in the spring, and 3) infected mosquitoes hibernate over 
winter and infect birds the following spring. 
There has been only one isolation of WEE from hiber¬ 
nating mosquitoes (5^)* Reeves (52) was unable to recover 
WEE from C. tarsalis in California during a period from 
November 15 to January 15 during a five year study, although 
he did isolate it at all other times during the year. 
To investigate the theory that migrating birds re¬ 
introduce the virus to endemic areas each spring, Kissling (6I1) 
tried to isolate WEE virus from birds wintering in Louisiana 
and Florida. He found no virus in 1,503 birds, although 
some had antibodies. 
A possible vector for carrying WEE over the winter 
is the wood tick (Dermacentor andersoni). Syverton and 
Berry (66) were able to transmit WEE to rodents in the 
laboratory with this anthropod. They also found that the 
* 
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offspring of infected ticks were infected and capable of 
transmitting the infection (67). There has, however, been 
no isolation of WEE from Dermacentor andersoni in nature. 
Thomas and Eklund (68) in i960 showed experimentally 
that artificially inoculated garter snakes could maintain 
infections of WEE through the winter and develop a viremia 
of sufficient titer after hibernation to infect mosquitoes. 
Again it must be stated that there has been no isolation 
in nature from these proposed hosts. Reeves (60) in 1963 
found no evidence of C, tarsalis having fed on reptiles, 
rodents, or amphibians in a study of blood meals with pre¬ 
cipitating antisera. 
In summary it can be said that WEE appears to be trans¬ 
mitted primarily by Culex tarsalis in a bird-mosquito-bird 
cycle (at least in the far west), that this cycle may be 
interrupted by transmission to another animal, and that it 
is not known whether the virus is maintained over the winter 
in endemic areas. 
Strain Variation in WEE 
The work of Olitsky (17) showing antigenic variation 
among strains of WEE has already been mentioned, as has the 
biological variation shown in sub-populations of WEE by 
Dunayevich and Johnson (22). In 1963 Karabatsos, et al, (69) 
showed marked differences between laboratory strains and 
recent isolates of WEE. All of the laboratory strains had 
undergone many mouse passages and were antigenically 
. 
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indistinguishable by HI, Neut or complement»fIxati on tests. 
The recent isolates were antigenically different from the 
high passage strains. More recent work by Henderson (23,214.) 
has shown the existence of antigenically distinct sub¬ 
populations of virus within various strains of WEE. Henderson 
also reacted 100 strains of WEE virus against antisera pre¬ 
pared against antigenically different plaques derived from 
one WEE strain and was able to group strains into three 
categories. Fifty three strains were neutralized by all 
three of the plaque antisera. These were called "aphasic 
strains." Thirteen strains were called "phase I," and 
3k strains were designated "phase II." Furthermore he found 
that strains from the western United States were aphasic or 
phase I, while phase II strains were found on the Atlantic 
and Gulf coasts, with the exception of one phase II strain 
found in Colorado. Phase I and phase II virus strains were 
found to convert to aphasic after a number of passages in 
mouse brain or rhesus monkey kidney culture, but aphasic 
strains were stable. No phase change was noted after passage 
in chick embryo tissue culture. 
MATERIALS AND METHODS 
Collection of Sera 
In the summer of 1962 a serum survey of United States 
military recruits was conducted under the direction of 
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Dr. J. R. Paul of the Department of Epidemiology and Public 
Health, Yale University School of Medicine, and under the 
auspices of the Armed Forces Epidemiological Board and the 
WHO Reference Serum Bank (70). The United States was 
divided into ninety divisions based on ecological considera¬ 
tions (Figure 1). An effort was made to secure sera from 
fifty recruits from each division with an equal number of 
recruits from each division with an equal number of recruits 
from rural (population under 2500) and urban communities. 
The blood samples were collected from recruits at seven 
training centers, about 500 samples from each center. 
All recruits filled out a questionnaire listing their 
age, ethnic group, birth place, residences, previous occupa¬ 
tion, poliomyelitis vaccinations, and exposure to animals. 
A sample questionnaire is shown in Figure 2. Candidates 
to be bled were selected on the basis of their place and 
duration of residence in one area. The majority had lived 
within a radius of fifty miles of their birth place all their 
lives, and a large proportion of the rest had lived within 
a similar radius for over half their lives. Geographic 
distribution of sample is shown in Figure 3. 
Blood was drawn prior to any immunizations. Disposable 
sterile needles fitted to 20 ml vacutainers were used. 
Blood was allowed to clot for twelve hours at 1|°C, then it 
was centrifuged for 15 minutes at 2000 rpm. The serum was 
pipetted into test tubes and recentrifuged to remove the 
, 
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few red cells usually transferred in the pipetting. The 
clear serum was frozen, packed in dry ice and flown to 
Yale University. Approximately 3200 sera were collected 
in this manner, and the geographical quotas were well 
realized. 
Since this survey represents only males from 1? to 
24 years of age who met the Armed Forces physical require¬ 
ments, it must be considered only a sample of the young, 
healthy, male population of the United States. It is 
not at all a representation of the population as a whole. 
Virus Strains 
Two strains of WEE virus, the McMillan and Alabama 
strains, were used to prepare the antigens for these ex¬ 
periments. The McMillan strain was isolated in 1941 from 
a fatal human case in Winnipeg, Manatoba (71)* The four¬ 
teenth mouse passage of the virus was used. Henderson (24) 
has shown that this virus is an aphasic form of WEE. 
The Alabama strain was isolated in Alabama in 1957. 
The fifth mouse passage was used in these experiments. 
The virus was found by Henderson (24) to be a phase II type. 
The Hemagglutination Inhibition Test 
Antigen Preparation —-- Antigens for HI tests were 
prepared according to the acetone-sucrose extraction method 
from brains of suckling mice as outlined by Clarke and 
Casals (72). 
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Extraction of Sera Work at the Yale virus labora¬ 
tory has shown that the kaolin method of extraction given 
by Clarke and Casals (72) resulted in a number of false 
positive reactions in the HI test with the recruit sera. 
Because of this the more tedious, but more reliable, 
acetone precipitation method was used (72). For this the 
sera were diluted 1:10 and 12 volumes of chilled acetone 
added. This mixture was allowed to stand for 5 minutes 
and then was centrifuged in the cold at 1,800 rpm. The 
supernatant was discarded and 12 more volumes of chilled 
acetone were added, and again the mixture was centrifuged. 
The supernatant was again discarded, and the sediment was 
dried for 30 minutes in a desicator attached to a vacuum 
pump. The dried sediment was rehydrated with 2 ml of 
borate saline, pH 9, and allowed to stand overnight in the 
refrigerator. The final treated sera were stored at -20°C 
until tested for HI antibodies. 
Preparation of Chick Erythrocytes --- Erythrocytes 
for HA and HI tests were obtained from 1-day-old chicks, 
which were bled by cardiac puncture. Blood was diluted 1:Ip 
in Alsever’s solution and stored in the refrigerator. Chick 
erythrocytes were washed three times in phosphate buffered 
saline (PBS) and resuspended to 10$. Aliquots of the stock 
10$ suspension were diluted twenty times with pH adjusting 
buffers for use in the HA or HI tests. 
Hemagglutination Titrations —- The HA test was 
. 
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performed to establish the titer of the antigen for sub¬ 
sequent use in the HI test, and to determine the optimal pH 
for each of the antigens. Clear plastic "agglutination trays" 
were used, each containing eighty shallow spherical wells 
about 3/1}.” in diameter. Tests were performed according to 
the method described by Clarke and Casals (72). Virus anti¬ 
gens were tested at five pH values: 6.2, 6.3, 6.1}., 6.6, and 
7.0. 
Results of each titration were read after one hour. 
Complete agglutination appeared as a thin, transparent 
shield of red cells over the whole surface of the wall. 
Lack of agglutination appeared as a red button in the center 
of the well. Virus titer was read as the last dilution 
giving complete hemagglutination. 
Hemagglutination-Inhibition Titrations --- HA antigen 
was diluted so as to give 1} to 8 units contained in 0.2 ml, 
based on the titer determined by the IIA test. This dilu¬ 
tion was calculated by dividing the HA titer by sixteen. 
Each serum used had been found to inhibit agglutination by 
WEE at 1:10 in an initial screening. Two-tenths ml bovine 
albumin-borate saline (BA-BS) was placed in each of five 
wells in the agglutination trays. Then, 0.2 ml of each serum 
at a 1:10 dilution was carried through five serial 2-fold 
dilutions (1:20 to 1:360). Two-tenths ml of the antigen 
containing 1} to 8 HA units was added to each well, and the 
mixture was left for one hour at room temperature. Then 
1 * 
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0.4 ml of a 1:200 chick erythrocyte suspension, made up 
in the appropriate pH buffer, was added to each well. After 
standing for one hour at room temperature, the hemagglutina¬ 
tion patterns were read. The titer of the serum was taken 
as that dilution which showed complete HI. 
Controls consisted of 0.4 ml of cells mixed with 
0.4 ml of BA-BS, and 0.4 ml of cells mixed with 0.2 cc of 
antigen and 0.2 ml of BA-BS. 
The Neutralization Test 
Preparation of Virus --- Suckling mice were intra¬ 
cerebral ly inoculated and the brains harvested and pooled. 
The group of brains were homogenized with sufficient PBS 
added to make a 10$ suspension. The homogenate was centri¬ 
fuged at 10,000 rpm for thirty minutes in the cold. The 
supernatant was pipetted into Wasserman tubes in 0.25 ml 
aliquots. Then, 0.25 ml of 10$ bovine albumin solution was 
added to each tube. All tubes were stored at -70°C. 
Preparation of Tissue Culture --- Chick embryo fibro¬ 
blast tissue cultures were used as described by Henderson 
and Taylor (73). Nine-day-old White Rock chick embryos 
were decapitated and minced with scissors. The minced tis¬ 
sue was washed with cold phosphate buffer and the cells 
dispersed with trypsin. The cell suspension was filtered 
through four layers of gauze. The cells in the filtrate 
were then washed three times in cold buffered saline, 
packed by low speed centrifugation, and resuspended at a 
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concentration of about 1 sl+OO in Hanks’ growth medium. 
Three-ounce prescription bottles were seeded with 8-10 ml 
from this suspension and incubated in a horizontal station¬ 
ary position at 37°C for three days prior to use. 
The Test ■—■ Log dilutions of each virus were mixed 
with equal amounts of 1:8 dilution serum. The mixture was 
allowed to stand at room temperature for one hour. Then 
0.2 ml of each virus-serum mixture was added to a tissue 
culture bottle (after discarding the growth medium). The 
inoculum was spread evenly over the cell sheet, and bottles 
were incubated in a horizontal position with the cell sheet 
down for one hour at 37°C. 
Each cell sheet was overlaid with an agar-medium. 
When the agar had cooled, all bottles were inverted and 
placed in the incubator at 37°C. Plaques appeared in 2-3 
days. At the en d of two days the number of plaques seen in 
each virus dilution was compared to control bottles of the 
same dilution without serum added. When comparing Neut 
titers obtained with test sera against the two virus strains, 
a difference of 1.5 logs was considered to be significant. 
CHEMICAL REAGENTS 
Borate-saline, pH 9»0 --- This solution is 0.05 M 
sodium borate and 0.12 M NaCl. It is made by diluting 80 ml 
of 1.5 M NaCl, 100 ml of 0.5 M Na borate and 2i+. ml of 1.0 M 
NaOH up to one liter with distilled water. 
, 
, 
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Bovine albumin-borate saline (BA-BS) --- A 1$ solu¬ 
tion of bovine albumin is made with borate saline and the pH 
is adjusted to 9.0 with 2 M NaOH. 
Buffers for HA and HI tests --- These buffers were 
prepared from mixtures of 0.15 M NaCl-0.2 M Na2HP0j^ and 0.15 M 
NaCl-0.2 M NaHgPO^. Clarke and Casals (72) list the pro¬ 
portions needed for making buffers which give pH values from 
5.75 to 7.1+ when mixed with equal volumes of borate-saline, 
pH 9.0. 
Hanks Growth Medium --- To make one liter the follow¬ 
ing proportions were used: 7&9 ml water; 100 ml of Hanks’ 
lOx concentrated; 100 ml of lactalbumin hydrolysate (5$); 
20 ml of calf serum (sterile); 7 ml of NaHCO^ (7«5$)> 
ij. ml of phenol red (0.5$); 1 ml of penicillin (200,000 u/ml) 
and 0.I4. ml of streptomycin (500,000 rag/ml). 
Agar preparation --- 2.1^ gms of Difco agar were used 
for each for each 90 ml of water. The agar was added to 
the water and melted in a bath of boiling water. Once 
dissolved, the agar was autoclaved at 15 lbs for 15 minutes 
and temporarily stored in a 56°C water bath. 
Agar overlay media --- The following amounts were used 
for each 90 ml of medium (enough for 16 3-ounce bottles): 
60 ml of sterile, demineralized water; 18 ml of Earle’s 
saline, lOx concentrated; 6 ml of yeast extract (1$ aqueous); 
6 ml of lactalbumin hydrolysate (5$ aqueous); 3.6 ml calf 
serum; 5«4 ml of NaHCO^ (7.5$); 3.0 ml neutral red (1:1000); 
■* 
. 
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0.2 ml of penicillin (2000,000 u/ml), and 0.1 ml of strepto¬ 
mycin (500,000 mg/ml). These were mixed thoroughly with 
an equal volume of melted agar just before use. 
RESULTS 
Hemagglutination Inhibition Tests 
Of the 3200 sera screened at a 1:10 dilution for HI 
antibodies to WEE virus, l\l were found to be positive. 
The screening was done with a phase II virus. Thirty-six 
of the 4l positives were available for titration against 
an aphasic (McMillan) and a phase II (Alabama) strain of 
WEE virus. 
Twenty-one showed no HI antibodies at a 1:20 dilu¬ 
tion when tested against the aphasic strain and a titer of 
only 1:10 against the phase II virus. Results of these 
titrations are shown in Table 1. It will be noted that the 
residences of the recruits from whom these sera were obtained 
were largely confined to the East and the Midwest. The 
other 15 sera tested had a titer of 1:20 or greater against 
one or both of the test viruses. Results of titration of 
sera are shown in Table 2. These samples were from resi¬ 
dents living in the West and the Far West. 
Two of these sera showed a four-fold difference between 
the titers when tested against the two virus strains. These 
sera, #894 ami #2323* were from recruits living in Fresno 
County, California. It is of interest that #894 showed a 
,v: 
, 
four-fold Increase in antibodies to phase II virus but not 
apbasic virus, while #2323 showed just the opposite. A 
third serum, #1362, gave a relatively low titer (1:40) 
against the phase II virus and a titer of less than 1:20 
against the aphasic strain. 
It is also of some interest that I4 of these 15 sera 
were from recruits living in Nebraska. 
Neutraliz ation Tests 
Of the 1|_1 sera which were positive for WEE by HI 
screening, 29 were available for tissue culture neutraliza¬ 
tion tests with the aphasic and phase II strains of the 
virus. The plaque-forming unit (PFU) log reductions by 
these sera against each virus are shown in Table 3» Nine 
of these sera (#698, #887, #1014-7, #1285, #1359, #1397, 
#2323, #214.03, and #2517) showed a significant neutraliza¬ 
tion titer when using one or both of the virus strains. 
All nine showed significant titers against the aphasic 
virus, but only four had significant titers against both 
viruses. 
When sera #698 and #1285 were tested in the plaque re¬ 
duction neutralization test against the two virus strains, 
there was a 1.5 or more log difference in titer. There were 
differences of lesser magnitude noted in 6 other sera (#1014-7, 
#1359, #2323, #214-03, #25l7)* In two of these the greater 
titer was against the phase II antigen. In four, however, 
the higher titer was against the aphasic antigen. The two 
% 
- 
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sera which had a greater neutralizing capacity for the 
phase II strain of WEE were from recruits living in 
Nebraska. 
Variation between HI and Neut Test Results 
In Table 4 are compared data obtained from sera on 
which both HI and Neut tests were run and which showed sig¬ 
nificant differences in titers against the two virus strains 
measured by either test. It will be noted that serum #694 
was of borderline significance by both tests. The HI and 
Neut differences were not always of the same magnitude. 
Serum #1285 showed a marked difference when reacted against 
the two phase viruses by Neut, but no difference by HI 
test. Serum #2323 showed a six-fold difference between the 
two phase viruses by HI test, but a log PPU reduction dif¬ 
ference of only 1.2. 
DISCUSSION 
Thirty-eight sera were tested in this study and of 
these, seventeen showed significant antibody levels by the 
HI or Neut test. Even though this is far too meagre a 
sample to provide conclusive data concerning antibody type 
variation in WEE, certain aspects of the study deserve 
comment. 
One of the most striking findings was the geographic 
division between the viruses which had an HI titer of only 
• 
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2. Twenty-one sera had an HI titer of only 1:10 and six¬ 
teen of these were tested by Neut and found to have no titer. 
Most of these sera were from donors living in the eastern 
U. S. The sera showing significant HI and/or Neut titers 
were from donors in the mid- and far west. 
3. Eight sera showed a significant difference in antibody 
levels to the two phases of WEE virus by one or both of 
the tests. The Neut test gave better differentiation between 
the two strains. 
ij.. Antibody type, resulting from infection by aphasic or 
phase II viruses and demonstrated by the Neut test, seems to 
have a similar geographic distribution as that of the dif¬ 
ferent antigenic phases of WEE virus. Results with the HI 
test are ambiguous on this point. 
a 
* 
■ 
In this study the sera which showed a higher level of anti¬ 
bodies to the aphasic strain of WEE were from recruits 
living in North Dakota and South Dakota, California, Oklahoma, 
and Washington. This distribution corresponds to the areas 
in which aphasic virus has been isolated. The sera which 
had a higher Neut titer to the phase II strain were both 
from recruits living in Nebraska. Although no phase II 
virus has been isolated in this state it has been isolated 
in the neighboring state of Colorado. 
The two sera which showed antibody strain variation 
by the HI test were both from residents of Fresno, California. 
One showed a higher HI titer to the aphasic strain as might 
be predicted, but the other (#894) showed a higher titer 
against the phase II form. 
A phase II strain of WEE has never been isolated in 
California, and the high titer of serum #894 to phase II is 
puzzling. According to their donor’s questionnaire he lived 
for two years (1957-59) in Maine. Since this is the region 
where phase II isolates of WEE have been made, it may be 
that he acquired his infection there. 
SUMMARY 
1. Thirty-eight sera which were known to have HI antibodies 
to WEE virus at 1:10 dilution were tested by HI and Neut 
tests against two strains of WEE virus representing different 
antigenic phases. 
. 
, 
, 
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1:10, and those which had a more significant antibody level. 
Sixteen of the twenty-one sera with an HI titer of 1:10 were 
from recruits living east of the Missouri River, and eight 
of them were from recruits living in Atlantic coastal states. 
In contrast the 1? sera with more significant HI or Neut 
titers were from recruits living west of the Missouri River 
with only one exception; this exception, from Iowa, was of 
borderline significance. 
Sixteen of the twenty-one sera with an HI titer of 
1:10 were tested by Neut, and none were found to show signifi¬ 
cant neutralization, while all of the sera with higher HI 
titers that were tested by Neut were found to have significant 
neutralization titers. 
The failure of the sera with HI titer of 1:10 to neu¬ 
tralize WEE, together with their geographic distribution, 
suggest that their donors may have been infected with another 
arbovirus related to WEE, and their low HI titer represents 
a cross reaction. The only other serogroup A virus known to 
be active in the eastern United States is EEE. These same 
sera were screened for HI antibodies to EEE in another study, 
and none of them were positive. 
The low HI titer of these sera may also be the result 
of non-specific inhibitors or very old WEE infections, but 
in either case it would be hard to explain why they were not 
randomly distributed across the country instead of being 
localized in the East. 

27 
Of the two tests the Neut test seemed better able 
to pick up differences in antibodies to the two strains. 
Of the five sera showing borderline or significant anti¬ 
body variation by Neut, there are HI titers for only four. 
In only one case does the HI test show a significant degree 
of antibody variation. 
It is interesting to speculate why a few sera showed 
antibody variation, and the rest do not. It may be that 
sera which do not show antibody strain variation are from 
individuals who have been infected more than once with WEE, 
the second infection causing an amnestic response with in¬ 
creased titer to all the antigens of the virus. Some of 
these sera may also represent old infections with WEE in 
which the originally high titer to one strain has declined. 
Other factors such as the previous experience of the in¬ 
fected individual with other serogroup A viruses, the amount 
of the inoculum, the severity of the infection, all may play 
a part in determining whether the serum antibodies will show 
strain specificity. 
Prom the data here, it might have been concluded that 
antibody strain variation can be determined in sera of some 
individuals previously infected with WEE, but such antibody 
variation is not always found. 
In Henderson’s study (2i|) the phase II of WEE virus 
was found on the east coast, while the phase I and aphasic 
forms of the virus were isolated in the mid- and far west. 
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TABLE 1 
Sera Inhibiting Hemagglutination at a 1:10 Dilution Only 
Using Alabama (Phase II) Virus as HA Antigen 
Serum Residence of Recruit 
City County State 
18 Elmhurst Queens N.Y. 
71 Union City Hudson N.J. 
9l+ Woodsville Grafton N.H. 
100 Elizabeth Union N.J. 
10?8 Washington Franklin Mo. 
1106 Marl ow Stevens Okla. 
1108 Britt Hancock Iowa 
1121 Santa Pe Santa Pe N.M. 
1151+ Brownfield Terry Texas 
H57 SpringfieId Greene Mo. 
1177 Stewartville 01mstead Minn. 
1252 No. Vernon Jennings Ind. 
1293 Bettendorf Scott Iowa 
1313 Hersey St. Croix Wis. 
1376 Ardmore Carter Okla, 
H+92 Hamburg Calhoun Ill. 
1503 Martin Bennet S.D. 
1861+ Cadyville Clinton N.Y. 
1865 C ow ard Florence S.C. 
1866 Belvedere Aiken s.c. 
1868 Easley P ic te ns S.C. 
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TABLE 2 
Sera, with HI Titers Greater Than 1:10 Using Two Antigenic ally 
Different WEE Strains (McMillan and Alabama) 
<. 
Serum WEE Virus Strains Residence of Recruit 
McM Ala City County State 
694 20* 10* Farmington San Juan N.M. 
894 40 160 Fresno Fresno Calif 
1047 80 40 Rapid City Pennington S.D. 
1052 20 20 Grant Perkins Nebr. 
1285 40 40 Alva Woods Okla. 
1324 80 80 Avendale Manicopa Ariz. 
1330 20 10 Stockton Rooks Kan. 
1359 80 160 Lindsay Platte Nebr. 
1362 4 20 40 Cheyenne Laramie Wyom. 
1371 <20 20 Davenport Scott Iowa 
1397 160 160 Sidney Cheyenne Nebr. 
1455 - 160 Kimball Kimball Nebr. 
2323 320 40 Firebaugh Fresno Calif 
2403 40 20 Mt. Vernon Skagit Wash. 
2517 40 20 Grafton Walsh N.D. 
Reciprocal of highest dilution of serum giving HI 
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TABLE 3 
Neutralization Test Titers Using Antigenically Different 
WEE Strains 
Serum WEE Virus Strains Residence of Recruit 
McM Ala City County State 
100 0.4* 0* Elizabeth Union N.J. 
694 1.4 1.3 Farmington San Juan N.M. 
698 4.1 1.5 Carrington Foster N.D. 
88? 1.8 1.2 Whittier Los Angeles Calif 
10ii7 1.7 0.9 Rapid City Pennington S.D. 
1052 0.4 0 Grant Perkins Nebr. 
1078 0.4 0 Washington Franklin Mo. 
1106 0.2 o.5 Marlow Stevens Okla. 
1108 0 0.1 Britt Hanc oc k Iowa 
1121 0.1 0.1 Santa Fe Santa Fe N.M. 
115? 0.4 0,1 Springfield Greene Mo. 
1177 0.4 0 Stewartville Olmstead Minn. 
1252 0.1 0 No. Vernon Jennings Ind. 
1285 2.7 1.0 Alva Woods Okla. 
1293 0.1 0.6 Bettendorf Scott Iowa 
1359 2.2 2.9 Lindsay Platte Nebr. 
1362 - 0.2 Cheyenne Laramie Wyom. 
1371 0.2 0.2 Davenport Scott Iowa 
1376 - 0 Ardmore Carter Okla. 
1397 2.5 3.2 Sidney Cheyenne Nebr. 
1U-92 - 0 Hamburg Calhoun Ill. 
1503 0.6 0.7 Martin Bennet S.D. 
186£J. 0.4 0.1 Cadyville Clinton N.Y. 
1865 0.4 0.1 Coward Florence s.c. 
1866 0.2 0.2 Belvedere Aiken S.C. 
1868 0.4 0 Easley Pickens S.C. 
2323 3.0 1.8 Firebaugh Fresno Calif, 
2i^03 2.5 1.4 Mt. Vernon Skagit Wash. 
2517 2.5 1.2 Grafton Walsh N.D. 
Log10 PPU Reduction 
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TABLE 4 
Summary of Representative Results of Differences in 
Antibody Levels Against Two Antigenically Distinct 
WEE Strains Using the HI and Neut Tests 
Serum HI Neut 
No. McM Ala McM Ala 
694- 20* 10* 1.4** 1.3** 
10k? 80 ^0 1-7 0.9 
1285 4-0 4-0 2.7 1.0 
1359 80 160 2.2 2.9 
1397 160 160 2.5 3.2 
2323 320 4-0 3.0 1.8 
2403 4-0 20 2.5 1.4- 
2517 4-0 20 2.5 1.2 
Reciprocal of highest dilution of serum giving HI 
Log-j_Q PFU Reduction 

35 
LEGEND FOR FIGURE 1 
Map of the United States showing the 90 ecological 
divisions on which the selection of the recruit samples 
was based. 
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Figure 1 

LEGEND FOR FIGURE 2 
A questionnaire of the kind filled out by each recruit 
prior to his inclusion in the serum survey. 
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Ethnic data: 
Specimen for test obtained by: 
Specimen Code No.: 
Place: . 
Date: 
Name: 
Do not write above this line. 
Age: Birthdate: 
(last) (First) (Middle Initial) Day Month Year 
Armed Forces Serial No.:  Height: 
Present Hometown: 
Weight: 
Approximate population 
size: 
City (Place) 
Previous Residence 1) . 
State 
City (Place) 
Previous Residence 2) 
City (Place) 
State 
State 
Approximate date 
moved from: 
Approximate date 
moved from: . 
Birthplace: 
City (Place) State Country 
Former Occupation(s):  
No. of Brothers and Sisters (total): No. older Brothers: No. older Sisters: 
Have you had a family Dog? Yes No Cat? Yes No Farm Animals? Yes No 
Have you been vaccinated against polio? Yes No Unknown (If yes, how many shots?) 
Have you taken polio vaccine by mouth? Yes No 
Do not write below this line. For Office use only. 
Code No.: 
Induct. 
Center: 
Age: 
Birthplace: 
Ethnic Gp. 
Home State: 
Prev. States: 
Urban-rural: ... 
Prev. Res. (1): 
Mobile: . 
Occupations: 
No. of 
siblings: 
Sibling 
position: 
Expos, to 
animals: 
Soc.-Econ. Gp. 
Vaccination 
against 
polio: 
No. inoc. 
Oral: . 
Figure 2 
' 
LEGEND FOR FIGURE 3 
Map of the United States showing place of residence of 
each of the recruits included in the survey. Each dot 
represents one recruit. 

ko 
Figure 3 

LEGEND FOR FIGURE 
Top - Map showing the places where aphasic strains of 
WEE have been isolated, and the residences of 
the recruits with aphasic neutralizing antibody. 
Bottom - Map showing the places where phase II strains of 
WEE have been isolated, and the residences of the 
recruits with phase II neutralizing antibody. 

Figure Ij. 
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